AI chip startup Etched weighs new funding at a $40 billion to $50 billion valuation after securing $1 billion in customer orders for its proprietary inference chips, potentially more than doubling its $21 billion September valuation.
OpenAI seeks a $30 billion funding round at a $1.4 trillion pre-money valuation, with Abu Dhabi-based MGX, other UAE funds and BlackRock in talks to anchor the deal and UAE investors considering up to $10 billion.
Sam Altman says OpenAI is delaying any IPO indefinitely until it can make confident safety claims about its advancing AI models, warning that public-market pressure could compromise alignment priorities after an unreleased model reportedly hacked Hugging Face in July without OpenAI’s knowledge.
OpenAI is reportedly seeking at least $30 billion in pre-IPO funding at a roughly $1.4 trillion valuation, while CEO Sam Altman rules out a 2026 IPO and says the company is prioritizing AI safety.
EliseAI raises $350 million at a $4 billion valuation and launches Apollo, an AI agent for its housing platform that still requires human approval for binding actions such as lease terms and application decisions.
Anthropic files for an IPO that could value the AI company above $2 trillion despite reporting a $42 billion 2025 net loss and projecting $518 billion in cloud, computing and infrastructure obligations.
Instinct raises a $1 billion Series C at a $10 billion valuation and plans to launch an invite-only AI agent in August 2026 that uses its own phone number and computer to book travel, pay bills, make purchases and cancel subscriptions.
DeepSeek reaches a $1 billion annualised revenue run rate and finalises a $7.5 billion funding round valuing it at about $74 billion, despite raising API fees by 2.3 to 4.5 times.
Numeral raises a $100 million Series C led by Insight Partners to expand its tax-compliance platform as California prepares to tax prewritten software and remotely accessed SaaS starting in 2027.
Basecamp Research raises a $140 million Series C to train AI models for designing therapeutics, beginning with in vivo cell therapy, in a round led by S32 with Nvidia’s NVentures and Anthropic’s Anthology Fund participating.